In-vitro Testing of Arsenic Sulfide Nanoparticles for the Treatment of Multiple Myeloma Cells
نویسندگان
چکیده
In this study, αand β-phase As4S4 nanoparticles were prepared by wet nanomilling using sodium dodecyl sulfate as a surfactant. The properties of the nanoparticles were characterized by particle size distribution and Raman scattering. A monomodal distribution, in the 150 – 200 nm range characterized the particle size of both phases after milling. Raman scattering revealed a common pattern for all studied particles. The existence of pararealgar was documented by Raman spectroscopy. The anticancer effects, of the milled species were confirmed for two multiple myeloma cell lines (RPMI-LR5 and OPM1) invitro.
منابع مشابه
In vitro Effect of Pomalidomide on Bone Marrow Mononuclear Cells from Multiple Myeloma Patients
Background: Many features of anticancer drugs, including cytotoxicity and/or cytokine induction, are studied using cell lines orhuman blood leukocytes. However, in a disease such as multiple myeloma, most cancerous cells are resided within bone marrowmononuclear cells. In the present study, we investigated the effect of pomalidomide on apoptosis and IL-2 production of bonemarrow mononuclear cel...
متن کاملArsenic in Cancer Treatment: Challenges for Application of Realgar Nanoparticles (A Minireview)
While intensive efforts have been made for the treatment of cancer, this disease is still the second leading cause of death in many countries. Metastatic breast cancer, late-stage colon cancer, malignant melanoma, multiple myeloma, and other forms of cancer are still essentially incurable in most cases. Recent advances in genomic technologies have permitted the simultaneous evaluation of DNA se...
متن کاملبررسی پاسخ به درمان با آرسنیک تریاکسید در بیماران میلوم متعدد مقاوم به درمان
Normal 0 false false false EN-US X-NONE AR-SA MicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal" mso-tsty...
متن کاملStudy of Multiple Myeloma Occurrence in Patients With 5%-10% Bone Marrow Plasma Cells: A Case Series Regarding Revised IMWG Diagnostic Criteria
Introduction: Utilizing lower limit of bone marrow plasma cells (BMPCs) is the main existing criterion for diagnosis of multiple myeloma (MM). According to the revised international myeloma working group (IMWG) diagnostic criteria, the value of 10% is agreed among experts as the cutoff level for diagnosis. Symptomatic patients with BMPC above this value are identified as definite cases of MM. H...
متن کاملStudy of Multiple Myeloma Occurrence in Patients With 5%-10% Bone Marrow Plasma Cells: A Case Series Regarding Revised IMWG Diagnostic Criteria
Introduction: Utilizing lower limit of bone marrow plasma cells (BMPCs) is the main existing criterion for diagnosis of multiple myeloma (MM). According to the revised international myeloma working group (IMWG) diagnostic criteria, the value of 10% is agreed among experts as the cutoff level for diagnosis. Symptomatic patients with BMPC above this value are identified as definite cases of MM. H...
متن کامل